Assessment of Residual Skeletal and Dental Growth in Children: A Cross-Sectional Study Using Quantitative Cameriere Methods
Abstract
Background/Objectives: Accurate assessment of biological maturation is essential in pediatric dentistry and orthodontics for optimizing treatment timing. Quantitative methods proposed by Cameriere allow continuous estimation of residual skeletal and dental growth; however, the degree of agreement between these maturation processes remains unclear. This study aimed to assess residual skeletal and dental growth in children using quantitative Cameriere methods and to evaluate the agreement between these two maturation indicators. Methods: This cross-sectional observational study included 98 Caucasian subjects (50 males and 48 females) aged 7.0–11.9 years. Residual skeletal growth was assessed on lateral cephalometric radiographs using the fourth cervical vertebra ratio (C4-Vba), while residual dental growth was evaluated on panoramic radiographs using the open apices method. Measurements were performed using the AgEstimation Project software v1.0. Intra- and inter-observer reproducibility were assessed using intraclass correlation coefficients (ICCs). Correlation analysis and Bland–Altman analysis were performed to evaluate the association and agreement between skeletal and dental maturation. Results: Excellent reproducibility was observed for all measurements, with ICC values ranging from 0.93 to 1.00. Residual skeletal growth time (T_skeletal) and residual dental growth time (T_dental) showed a weak positive association (Spearman ρ = 0.18, p = 0.09). Discrepancies exceeding…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 98 participants or records.
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.